NEW YORK (GenomeWeb News) – Biomolecular analysis and proteomics company Phoenix S&T has received a $500,000 investment from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania.
 
BioAdvance said today that it has provided the Chester, Pa.-based company with the funding as one of three firms it has newly invested in with a total of $1.5 million.
 
PST has patented injection molded nanospray devices used in biomolecular analysis for proteomics and clinical diagnostics applications.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.